Bridgebio Pharma shares owned by Context Capital Management
Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Context Capital Management
from 13F filings
Historical chart of Context Capital Management investment in Bridgebio Pharma
Tip: Access up to 7 years of quarterly data
All positions including Bridgebio Pharma held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bridgebio Pharma by Context Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $97M | 98k | 988.25 |
| 2025-06-30 | $68M | 73k | 936.00 |
| 2025-03-31 | $64M | 70k | 901.50 |
| 2024-12-31 | $59M | 69k | 858.00 |
| 2024-09-30 | $52M | 61k | 840.00 |
| 2024-06-30 | $39M | 48k | 796.85 |
| 2024-03-31 | $30M | 36k | 824.06 |
| 2023-12-31 | $21B | 25M | 851.90 |
| 2023-09-30 | $24M | 32k | 749.68 |
| 2023-06-30 | $21M | 34k | 618.89 |
| 2023-03-31 | $17M | 27k | 647.37 |
| 2022-12-31 | $6.3M | 17k | 381.88 |
| 2022-09-30 | $7.4M | 17k | 447.50 |
| 2022-06-30 | $6.7M | 17k | 408.68 |
| 2022-03-31 | $11M | 23k | 488.24 |
More positions owned by Context Capital Management
View all positions for Context Capital Management